IN THE PRESS AllArticlesAudioVideo Both Sides of the Aisle Have Misguided Views on Intellectual-Property Rights | National Review | 04/26/2024Articles Why Prescription Drugs Cost So Much | The Washington Post | 04/12/2024Articles Public Health Still Needs an Economics Transfusion | National Review | 03/21/2024Articles COVID Lessons Learned: A Retrospective After Four Years | Committee to Unleash Prosperity | 03/15/2024Articles The White House Wants to Double Dip on Drug Rebates | RealClearHealth | 03/15/2024Articles 5th Annual CERSI Innovations in Regulatory Science Summit | UCSF-Stanford CERSI | 01/31/2024Articles Pharma Patents and the American Way of Innovation | WSJ | 12/19/2023Articles Former White House Economic Adviser Discusses Covid Policies at HUEA Event | Harvard Undergraduate Economics Association | 12/01/2023Articles Are PBMs Good For Competition? A Cost-Benefit Analysis of the Effects of Regulating Pharmacy Benefit Managers | Our Curious Amalgam | 10/2/23Audio The IRA’s Impact on Cancer Patients Is Worse than Predicted | RealClear Health | 10/24/2023Articles We Need More ‘Warp Speed’ Operations | WSJ | 10/6/23Articles The Problems with Drug Price Controls | The National Review Capital Matters | 9/27/23Articles Gilead-backed study warns IRA price negotiations could hit R&D harder than expected | Fierce Biotech | 09/06/2023Articles The SMART Prices Act Deserves a Failing Grade | RealClearHealth | 07/31/2023Articles A new Alzheimer’s drug wins FDA approval, but why it may still be out of reach. | USA Today | 07/07/2023Articles The SMART Prices Act is anything but smart | The Hill | 06/29/23Articles Three reforms that will lower Medicare costs and improve care | The Hill | 06/25/23Articles Casey Mulligan on Vaccines, the Pandemic, and the FDA | The Library of Economics and Liberty | 05/22/23Audio Tomas Philipson: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans | The Chicago Tribune | 05/18/2023Articles No, Lockdown States Did Not Do Better | National Review | 04/19/2023Articles Legislators should monitor mission creep at CMS’s flush price control center | The Hill | 04/12/23Articles The Deadly Side Effects of Drug Price Controls | WSJ | 4/5/23Articles Profitable Science Empowers Patients | Washington Examiner | 3/14/23Articles EDITORIAL: The side effects of drug price controls | The Review Journal | 02/17/23Articles How Deadly Were the Covid Lockdowns? | WSJ | 01/11/23Articles Tomas Philipson: Health care policy is ‘most damaging’ issue not discussed by economists | Fox News | 11/21/22Video The Inflation Reduction Act Comes for Medicare | WSJ | 11/21/22Articles In Defense of Pharmacy Benefit Managers | WSJ | 07/11/22Articles The Economics of Obesity | WSJ | 06/28/22Articles President Biden’s unintended war on cancer patients | The Hill | 06/28/22Articles Lockdown Damage | City Journal | 06/13/22Articles The Value of Employer-Sponsored Health Insurance: A Summary | American Action Forum | 04/12/22Articles A Final Report Card on the States’ Response to COVID-19 | April 2022Articles, Infectious Disease, Regulation NBER Spotlight – Substance Abuse and the COVID-19 Pandemic | NBER | 2/7/23Video An Economic Evaluation of Covid Lockdowns | WSJ | 1/19/22Articles The Backward Art of Slowing the Spread? Congregation Efficiencies During Covid 19 | The Hoover Institution – Stanford University | 01/19/22Video House Committee on Energy and Commerce Hearing – The Future of Biomedicine: Translating Biomedical Research into Personalized Health Care | 12/8/21Video Biden’s Price Controls Will Make Good Health More Expensive | WSJ | 09/15/21Articles Government Failure Gave the World Covid | WSJ | 8/9/21Articles How Chicago Economics is Helping End a Pandemic: Enabling Choice and Competition in Healthcare | 2/5/21Video Is the COVID cure worse than the disease? | The Hill | 02/06/21Articles Deaths of Despair and the Incidence of Excess Mortality in 2020 | VOX, CEPR Policy Portal (voxeu.org) | 1/28/21Articles Deaths of Despair and the Incidence of Excess Mortality in 2020 | CEPR | 01/28/21Articles Should Double Charging Patients for Medication be Legal? | Newsweek | 01/14/21Articles How Government Subsidized the Opioid Crisis | WSJ | 1/3/21Articles How Government Subsidized the Opioid Crisis | WSJ | 01/03/21Articles Operation Warp Speed: What a Deal! | Newsweek.com | 7/28/20Articles Operation Warp Speed: What a Deal! | Newsweek | 07/28/20Articles Corona Economics | Casey B. Mulligan | Friedberg Economics Institute | 05/25/20Video Some Basic Economics of COVID-19 Policy | Chicago Booth | 04/27/20Articles
